Urine test could revolutionize thyroid cancer Follow-Up
NCT ID NCT07532356
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to improve how doctors predict and monitor thyroid cancer by combining genetic testing of tumors with protein analysis from urine samples. Researchers will follow 100 newly diagnosed thyroid cancer patients to see if these markers can detect early signs of recurrence or spread better than current methods. The goal is to create a more precise and non-invasive way to personalize treatment and follow-up care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENOMICS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genetic test may spare patients from unnecessary thyroid surgery
- Can a new oral drug outsmart Radioiodine-Resistant thyroid cancer?
- Can an immune booster make radioiodine more effective against thyroid cancer?
- Hidden thyroid cancers may be more common in Graves' disease than thought
- Can math make thyroid hormone therapy more precise?
- Can AI help surgeons see thyroid cancer more clearly?